What is HEM stock price?

HEM (Hemostemix Inc) is currently trading at $0.08 on the Toronto Stock Exchange (TSX).

Stocks/TSX-V/HEM

Hemostemix Inc (HEM : TSX-V)

Common Stock

$0.07

CAD

+0.00 (7.14%)

Last updated: 2026-08-17

Get HEM alerts:

HEM

Hemostemix Inc

Source:

WealthAwesome

↑ $0.02 (36.36%)

30 day period

Performance

1 Day

+7.14%

1 Week

+15.38%

1 Month

+15.38%

YTD

-16.67%

Key Statistics

Market Cap

$13.32M

52W High

$0.14

52W Low

$0.04

P/E Ratio

50 Day MA

$0.06

200 Day MA

$0.07

Beta

0.61

Dividend Yield

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

Date	Open	High	Low	Close	Adj Close	Volume
8/17/2026	$0.07	$0.07	$0.07	$0.07	$0.07	11,920
8/13/2026	$0.07	$0.07	$0.07	$0.07	$0.07	124,563
8/10/2026	$0.07	$0.07	$0.07	$0.07	$0.07	83,797
8/7/2026	$0.07	$0.07	$0.07	$0.07	$0.07	1,001
8/6/2026	$0.07	$0.07	$0.07	$0.07	$0.07	5,465
8/5/2026	$0.07	$0.07	$0.07	$0.07	$0.07	8,911
7/31/2026	$0.06	$0.07	$0.06	$0.06	$0.06	24,384
7/29/2026	$0.07	$0.07	$0.06	$0.06	$0.06	32,635
7/28/2026	$0.07	$0.07	$0.07	$0.07	$0.07	179,822
7/27/2026	$0.06	$0.06	$0.06	$0.06	$0.06	21,000

Analyst Price Targets

Based on analyst covering HEM

📈

Wall Street analysts forecast HEM stock price to rise 1180.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.96

+1180.0% Upside

Current Price

C$0.07

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on HEM's historical volatility

HistoricalForecast68%95%

30-Day Vol

140.1%

Annualized

90-Day Vol

116.5%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$0.09

Expected price

Horizon	Expected	68% Range (1σ)	95% Range (2σ)
30 trading days	C$0.08	C$0.05 – C$0.13	C$0.03 – C$0.21
60 trading days	C$0.08	C$0.04 – C$0.17	C$0.02 – C$0.33
90 trading days	C$0.09	C$0.04 – C$0.21	C$0.02 – C$0.48

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Hemostemix Inc

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II clinical trial for the treatment of peripheral arterial disease, chronic limb threatening ischemia, cardiovascular ischemia and angina, and vascular dementia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.

Financials

Revenue (TTM): $0
EBITDA: $-4.88M
Profit Margin: 0.00%
ROE (TTM): 0.00%
EPS (Diluted): -0.02
Book Value: -0.03

Classification

Sector: Health Care
Industry: Biotechnology
Group: Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Explore More

Stock Screener TSX Stocks TSXV Stocks

Common Questions About HEM

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →

Ticker	Name	Price	1D
TNX	TenX Protocols Inc.	$47.24	+55476.47%
VTT	Vendetta Mining Corp	$0.01	+50.00%
WEC	Winchester Equity Corporation	$0.01	+50.00%
GOOD	Aquarius AI Inc	$0.14	+47.37%
CHII-P	Chicane Capital II Corp.	$0.07	+40.00%
FMM	Full Metal Minerals Ltd	$0.07	+40.00%
CAI	Capitan Investment Ltd	$0.02	+33.33%
CELL	Grid Battery Metals Inc.	$0.02	+33.33%

HEM.V news timeline

15 articles covering HEM.V, most recent first

Latest

Why Hemostemix Inc stock surged yesterday

Aug 18, 2026•Stocks

CIBC Investor's Edge